[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.226.208.185. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 127
Citations 0
Correction
February 13, 2019

Transposed Data in a Table

JAMA Surg. Published online February 13, 2019. doi:10.1001/jamasurg.2019.0020

In the Original Investigation titled “Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival,” published in the August 2015 issue of JAMA Surgery,1 2 columns of data were transposed in a table. In Table 1, the information in the column headings was correct; however, the entire column of data for all patients should have appeared in the column for patients with C0 disease, and the column of data for patients with C0 disease should have appeared in the column for all patients. This article was corrected online.

References
1.
Thirunavukarasu  P, Talati  C, Munjal  S, Attwood  K, Edge  SB, Francescutti  V.  Effect of incorporation of pretreatment serum carcinoembryonic antigen levels into AJCC staging for colon cancer on 5-year survival.  JAMA Surg. 2015;150(8)747-755. doi:10.1001/jamasurg.2015.0871PubMedGoogle ScholarCrossref
×